Ferdinand von Walden

Ferdinand von Walden

Affiliated to Research | Docent

The Muscle Biology, Mobility and Exercise (MyoMove) Lab conducts multidisciplinary research aimed at understanding how skeletal muscle and physical activity influence human health and function across

Visiting address: Astrid Lindgrens Barnsjukhus, Q2:07, 17176 Stockholm
Postal address: K6 Kvinnors och barns hälsa, K6 Neuropediatrik von Walden, 171 77 Stockholm
Part of:

About me

  • I am an Associate Professor of Physiology and Principal Investigator of the Muscle Biology, Mobility and Exercise (MyoMove) Lab at the Department of Women’s and Children’s Health, Karolinska Institutet. I am also a pediatrician working at the Pediatric Neurology Clinic at Astrid Lindgren Children’s Hospital, NKS, Solna.

Research

  • The Muscle Biology, Mobility and Exercise (MyoMove) Lab conducts multidisciplinary research aimed at understanding how skeletal muscle and physical activity influence human health and function across the lifespan. Our research spans preclinical models and human studies, including both typically developing, healthy individuals and individuals with neurodevelopmental conditions across different stages of life.

    A major focus of the group is molecular muscle biology, with a particular interest in ribosomes, the protein-producing machinery of the cell. We investigate whether and how different types of ribosomes can shape the capacity of skeletal muscle to produce force and energy and adapt to physiological challenges such as inflammation and muscle damage. This translational research program focuses on understanding conditions of muscle dysfunction, such as neuromuscular disorders and sarcopenia.

    Another major research focus of the group is exercise physiology, where we study both acute responses and long-term adaptations to endurance and resistance exercise. Our studies include children, adolescents and adults, with a particular interest in how puberty and biological maturity shape the physiological response to exercise. We combine human physiology with molecular analyses of skeletal muscle to better understand the mechanisms underlying exercise adaptation.

    A third area focuses on skeletal muscle and physical activity in cerebral palsy. Here, we investigate muscle function, cardiorespiratory fitness and physical capacity using physiological, functional and molecular approaches. We also study how exercise and interventions focused on gross motor function can be used to support physical function in children with cerebral palsy, including the use of frame running. These studies aim to bridge fundamental muscle biology with real-world improvements in mobility, health, and quality of life.

Articles

All other publications

Grants

  • Interventions to Increase Physical Activity in Children and Young Adults with Motor Disabilities
    Stiftelsen Promobilia
    1 June 2025 - 31 December 2028
  • Swedish Research Council
    1 December 2022 - 30 November 2026
    Duchenne muscular dystrophy (DMD) is the most common form of muscular dystrophy with no effective treatment. In this project I propose to test a novel hypothesis that the loss of ribosome specialization observed in DMD patients is a primary factor driving the progression of the disease.Skeletal muscle typically express ribosomal protein L3-like (Rpl3-like), instead of the ubiquitously expressed Rpl3. Preliminary data suggests that RPL3-like-containing ribosomes have acquired a specialized function that is necessary for the maintenance of sarcomeric protein expression. Data from DMD patients and DMD animal models (mdx mouse & dogs) show a significant downregulation of Rpl3-like expression with a corresponding increase in Rpl3 expression. In support of my hypothesis, analysis of skeletal muscle from DMD patients revealed that titin and nebulin proteins were barely detectable despite only a modest decrease in their respective mRNA levels. Given these findings, I will test the hypothesis that the loss of ribosome specialization in DMD causes a gradual decrease in sarcomeric protein expression which contributes to the progression of the disease.Ribosome specialization represents a heretofore unrecognized level of gene regulation. Thus, this proposal is a radical departure from how the field currently thinks about the underlying cause of the muscle pathology associated with muscular dystrophy and potentially highlights the ribosome as a new therapeutic target for treating DMD.

Employments

  • Affiliated to Research, Department of Women's and Children's Health, Karolinska Institutet, 2025-2028
  • Assistant Professor, Department of Women's and Children's Health, Karolinska Institutet, 2019-2025

Degrees and Education

  • Docent, Karolinska Institutet, 2025
  • Degree Of Doctor Of Philosophy, Department of Physiology and Pharmacology, Karolinska Institutet, 2015
  • University Medical Degree, Karolinska Institutet, 2009
  • Master Of Medical Science, Karolinska Institutet, 2007

News from KI

Events from KI